Xiaoyan Michelle Zhang - 22 Nov 2021 Form 4 Insider Report for Ikena Oncology, Inc. (IKNA)

Role
Chief Scientific Officer
Signature
/s/ Douglas R. Carlson, as Attorney-in-Fact for Xiaoyan Michelle Zhang
Issuer symbol
IKNA
Transactions as of
22 Nov 2021
Net transactions value
$0
Form type
4
Filing time
23 Nov 2021, 20:01:55 UTC
Next filing
14 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKNA Stock Option (Right to Buy) Award $0 +176,699 $0.000000 176,699 22 Nov 2021 Common Stock 176,699 $13.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option shall vest and become exercisable on November 22, 2022, with the remainder vesting in 36 equal monthly installments thereafter.